Wyost (denosumab 120 mg/1.7 ml)

allergic asthma for the treatment of moderate to severe persistent asthma in adult and pediatric patients (6 years of age and above) who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids

chronic rhinosinusitis with nasal polyposis for the add-on maintenance treatment of severe chronic rhinosinusitis with nasal polyps in adult patients inadequately controlled by intranasal corticosteroids alone.

chronic idiopathic urticaria treatment of chronic idiopathic urticaria in adults and adolescents (12 years of age and above) who remain symptomatic despite H1 antihistamine treatment